Carlos D. Flombaum
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Nephrology top 2%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Ilya GlezermanEphraim S. CasperMark R. GreenThomas D. BrownBonnie J. TrochanowskiRobert T. HeelanDavid P. KelsenPeter G. Tarassoff
- Topics
- Chemotherapy-induced organ toxicity mitigation (6 papers)Renal cell carcinoma treatment (5 papers)Renal Diseases and Glomerulopathies (5 papers)
- Cited by
- NephrologyTransplantationOncology
- Partner nations
- United StatesFrancePoland
In The Last Decade
Carlos D. Flombaum
40 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 103
- Oncology 749
- Pulmonary and Respiratory Medicine 642
- Molecular Biology 590
- Nephrology 373
- Pathology and Forensic Medicine 349
Countries citing papers authored by Carlos D. Flombaum
This map shows the geographic impact of Carlos D. Flombaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos D. Flombaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos D. Flombaum more than expected).
Fields of papers citing papers by Carlos D. Flombaum
This network shows the impact of papers produced by Carlos D. Flombaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos D. Flombaum. The network helps show where Carlos D. Flombaum may publish in the future.
Co-authorship network of co-authors of Carlos D. Flombaum
This figure shows the co-authorship network connecting the top 25 collaborators of Carlos D. Flombaum. A scholar is included among the top collaborators of Carlos D. Flombaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos D. Flombaum. Carlos D. Flombaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 51 | |
| 3 | 26 | |
| 4 | 79 | |
| 5 | 81 | |
| 6 | 38 | |
| 7 | 33 | |
| 8 | 91 | |
| 9 | 175 | |
| 10 | 30 | |
| 11 | 136 | |
| 12 | 26 | |
| 13 | 9 | |
| 14 | Na speciation affects the Na-P-o5m relationship and may explain in part the hyponatremia of hypoalbuminemic states | 2 |
| 15 | 372 | |
| 16 | 20 | |
| 17 | 24 | |
| 18 | 4 | |
| 19 | 7 | |
| 20 | 7 |
About Carlos D. Flombaum
Carlos D. Flombaum is a scholar working on Nephrology, Hematology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (6 papers), Renal cell carcinoma treatment (5 papers) and Renal Diseases and Glomerulopathies (5 papers). The work is most often cited by research in Nephrology (373 citations), Transplantation (102 citations) and Oncology (749 citations). Carlos D. Flombaum has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Ilya Glezerman, Ephraim S. Casper, Mark R. Green, Thomas D. Brown, Bonnie J. Trochanowski, Robert T. Heelan, David P. Kelsen, Peter G. Tarassoff, Leonard B. Saltz and Ki Y. Chung. Their work appears in journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.